|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Expression of survivin correlated with vessel invasion is a marker of poor progress in small adenocarcinoma of the lung显示文摘 | Ikehara M Oshita F Kameda Y | 2002 | Oncol Rep2002，9，4： | 1 |
| 2 | Phase D study of paclitax-el and irinotecan with intercalated gefitinib in patients with ad-vanced non-small-cell lung cancer显示文摘 | Oshita F Saito H Murakami S | 2010 | Am J Clin Oncol2010，，： | 1 |
| 3 | Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung 显示文摘 | Ikehara M Oshita F Kameda Y | 2002 | Oncol Rep2002，9，4： | 1 |
| 4 | Prognostic impact of survivin, cyclin D1, integrin betal, and VEGF in patients with small adenocarcinoma of stage I lung cancer显示文摘 | Oshita F Ito H Ikehara M | 2004 | Am J Clin Oncol2004，27，4： | 1 |
| 5 | Prognostic impact of survivin,cyclin D1,integrin betal,and VEGF in patients with small adenocarcinoma of stage Ⅰ lung cancer显示文摘 | Oshita F Ito H Ikehara M | | 0，，： | 1 |
| 6 | Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung显示文摘 | Ikehara M Oshita F Kameda Y | 2002 | Oncol Rep2002，9，4： | 1 |
| 7 | Prognostic impact of Survivin, ERCC1 ,cyclin D1 ,integrin betal,and VEGF in patients with non - small adenocarcinoma of stage I - III lung cancer显示文摘 | Oshita F Ito H Ikehara M | 2004 | Am J Clin Oncol2004，27，4： | 1 |
| 8 | Expression of surviving correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung显示文摘 | Ikehara M Oshita F Kameda Y | 2002 | Oncol Rep2002，9，4： | 1 |
| 9 | Increased expression levels of p53 correlate with good response to cisplatin-based chemotherapy in non-small cell lung cancer显示文摘 | Oshita F Nishio K Kameda Y | 2000 | Oncol Rep2000，7，： | 1 |
| 10 | Phase Ⅱ study of nedaplatin and irinotecan with concurrent thoracic radiotherapy in patients with locally advanced non-small-cell lung cancer显示文摘 | Oshita F Ohe M Honda T | 2010 | Br J Cancer2010，9，103： | 1 |
| 11 | Expression of cyclin D1 but not of cyclin E is an indicator of poor prognosis in small adenocarcinomas of the lung显示文摘 | Ikehara M Oshita F Hiroyukiito | 2003 | Oncology Reports2003，10，： | 1 |
| 12 | Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung显示文摘 | Ikehara M Oshita F Kameda Y | 2002 | Oncol Rep2002，9，4： | 1 |
| 13 | Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcionma of the lung显示文摘 | Ikehara M Oshita F Kameda Y | 2002 | Oncol Rep2002，9，4： | 1 |
| 14 | Expression of Survivin Correlated with Vessel Invasion Is a Marker of Poor Prognosis in Small Adenocarcinoma of the Lung 显示文摘 | Ikehara M Oshita F Kameda Y | 2002 | Oncol Rep2002，9，4： | 1 |
| 15 | Expression of surviving correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung显示文摘 | lkehara M Oshita F Kameda Y | 2002 | Oncol Rep2002，9，4： | 1 |
| 16 | Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung显示文摘 | IKEHARA M OSHITA F KAMEDA Y | 2002 | Oncol Rep2002，9，4： | 1 |
| 17 | Novel hetero-duplex method using small cytology specimens with a re-markably high success rate for analyzing EGFR gene mu-tations with a significant correlation to geftinib efficacy innon-small-cell lung cancer显示文摘 | Oshita F’Matsukuma S’Yoshihara M | 2006 | Br J Cancer2006，95，8： | 1 |
| 18 | Prognostic impact of survivin,cyclin D1,integrin betal,and VEGF in patients with small adenocarcinoma of stage Ⅰ lung cancer显示文摘 | Oshita F Ito H Ikehara M | | 0，，： | 1 |
| 19 | Increased expression levels of cyclin-dependent kinase inhibitor p27 correlate with good responses to platinum-based chemotherapy in non-small cell hmg cancer显示文摘 | Oshita F Kameda Y Nishio K | 2000 | Oncol Rep2000，7，3： | 1 |
| 20 | Expression of survivin correlated with vessel invasion is amarker of poor prognosis in small adenocarcinoma of the lung 显示文摘 | Ikehara M Oshita F Kaneda Y | 2002 | Oncol Rep2002，9，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员